EDAP TMS SA (EDAP)
4.71
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
4.76
+0.05
(+1.06%)
After-Hours: 20:00
EDAP TMS SG&A Expense (Quarterly) : 10.30M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| DBV Technologies SA | 8.399M |
| Cellectis SA | 5.184M |
| Ascendis Pharma A/S | 158.13M |
| Akari Therapeutics Plc | 1.963M |
| Biodexa Pharmaceuticals Plc | -- |